Drug Type Small molecule drug |
Synonyms AMG-151, ARRY 403 |
Target |
Action activators |
Mechanism glucokinase activators(Glucokinase activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18N6O3S2 |
InChIKeyPCOMIRCNMMNOAP-CQSZACIVSA-N |
CAS Registry1138669-65-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | United States | 01 Sep 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | Czechia | 01 Sep 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | Estonia | 01 Sep 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | Poland | 01 Sep 2011 | |
Diabetes Mellitus, Type 2 | Phase 2 | Puerto Rico | 01 Sep 2011 |